TG Therapeutics reports triple therapy data from Phase I/II study of ublitux
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Seneca Biopharma reports data from Phase 2 study of NSI-566 in China
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Biogen"s stock is up 5% after Lilly reports positive data from an Alzheimer"s study
Shares of Biogen Inc. gained 5.6% in trading on Monday after another drugmaker shared positive clinical data about an experimental Alzheimer's disease treatment that is similar to a Biogen therapy under review by the Food and Drug A.....»»
Prevail Therapeutics Reports First Quarter 2020 Financial Results and Business Highlights
Phase 1/2 Trial of PR001 for Parkinson's Disease with GBA1 Mutations Ongoing; Study.....»»
BioXcel Therapeutics expects data from Phase 1b/2 study of BXCL701 in Q4
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gilead Sciences reports positive data in trial of remdesivir as treatment for COVID-19
Gilead Sciences Inc. said that its experimental COVID-19 therapy remdesivir met the main goal in a government-funded clinical trial and that a shorter dosing regimen was as successful as a longer one in a separate study......»»
Kazia Therapeutics shared interim data from phase II study of paxalisib
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mersana Therapeutics updates data from XMT-1536 Phase 1 dose escalation study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mersana Therapeutics to present updated data from the XMT-1536 Phase 1 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Provention Bio reports "positive" data from Phase 1b PREVAIL study of PRV-3279
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Avadel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
Completed enrollment for the pivotal REST-ON Phase 3 study in Q4 2019; data readout expected in Q2 2020 Raised $65 million in gross proceeds from privat.....»»
Hoth Therapeutics reports data on lupus therapy
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Adverum Biotechnologies Reports Robust Efficacy with Evidence of Dose Response from Cohorts 1 and 2 of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at Angiogenesis, Exudation, and Degeneration 2020
Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced new interim clinical data from th.....»»
Applied Genetic Slumps Despite Encouraging Data For Gene Therapy To Treat Rare Inherited Visual Disorder
Shares of Applied Genetic Technologies Corp (NASDAQ: AGTC) are tumbling Thursday despite the company reporting encouraging results from an Phase 1/2 study. 0 read more.....»»
Mersana Therapeutics expects data from XMT-1536 Phase 1 study in 1H20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Seelos Therapeutics announces interim data from Phase 1 study of SLS-002
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Applied Therapeutics reports results of Phase 2 ACTION-Galactosemia study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Xeris Pharmaceuticals reports "positive" phase 2 data in glucagon study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Agios Pharmaceuticals reports new data from DRIVE PK Phase 2 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Achillion reports "positive" data from Phase 2 danicopan, eculizumab study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Soleno Therapeutics expects topline data for Phase III DESTINY PWS study in 1H20
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»